Sarki Abba Abdulkadir

  • 2670 Citations
1990 …2022

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Training Experience

1999Residency, Barnes Jewish Hospital
2000Postdoctoral Fellowship, Washington University
2000Fellowship, Barnes Jewish Hospital

Research Interests

Sarki A. Abdulkadir, MD, PhD, is the John T. Grayhack Professor of Urological Research, Vice Chair for Research, and Professor of Urology and Pathology at Northwestern University Feinberg School of Medicine, Chicago. Dr. Abdulkadir’s research program is focused on understanding the molecular mechanisms that drive cancer initiation, progression and recurrence with the ultimate goal of developing therapies that interfere with these processes. His work has particularly focused on prostate cancer. Dr. Abdulkadir has a strong interest in genomics and gene regulation; oncogenic kinases as molecular therapeutic targets; as well as the use of in vivo lineage tracing to define the fates of specific cell populations in tumorigenesis. His work has shed light on the cellular origins of prostate cancer, cancer gene cooperation in tumorigenesis, and the development of novel therapeutic agents currently in preclinical and clinical development.

Education/Academic qualification

PhD, Johns Hopkins University

… → 1995

MD, Ahmadu Bello University

… → 1990

Fingerprint Dive into the research topics where Sarki Abba Abdulkadir is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

  • Research Output

    • 2670 Citations
    • 54 Article
    • 4 Review article
    • 1 Comment/debate
    • 1 Letter

    EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells

    Sagar, V., Vatapalli, R., Lysy, B., Pamarthy, S., Anker, J. F., Rodriguez, Y., Han, H., Unno, K., Stadler, W. M., Catalona, W. J., Hussain, M., Gill, P. S. & Abdulkadir, S. A., Nov 1 2019, In : Cell Death and Disease. 10, 11, 801.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial

    Carneiro, B. A., Konda, B., Costa, R. B., Costa, R. L. B., Sagar, V., Gursel, D. B., Kirschner, L. S., Chae, Y. K., Abdulkadir, S. A., Rademaker, A., Mahalingam, D., Shah, M. H. & Giles, F. J., Dec 1 2019, In : The Journal of clinical endocrinology and metabolism. 104, 12, p. 6193-6200 8 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Organoids increase the predictive value of in vitro cancer chemoprevention studies for in vivo outcome

    Njoroge, R. N., Vatapalli, R. J. & Abdulkadir, S. A., Jan 1 2019, In : Frontiers in Oncology. 9, FEB, 77.

    Research output: Contribution to journalReview article

    Open Access
  • 2 Scopus citations

    Prostate Stroma Increases the Viability and Maintains the Branching Phenotype of Human Prostate Organoids

    Richards, Z., McCray, T., Marsili, J., Zenner, M. L., Manlucu, J. T., Garcia, J., Kajdacsy-Balla, A., Murray, M., Voisine, C., Murphy, A. B., Abdulkadir, S. A., Prins, G. S. & Nonn, L., Feb 22 2019, In : iScience. 12, p. 304-317 14 p.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations